Canine cognitive dysfunction syndrome (CDS) is a neurodegenerative condition equivalent to Alzheimer's disease in humans, causing progressive cognitive decline in older dogs. Recognition and management significantly improves quality of life for affected dogs and their owners.
The DISHA framework provides a systematic recognition tool: Disorientation (getting lost in familiar environments, staring blankly, appearing confused); altered social Interactions (reduced greeting behaviour, altered relationships with family members, inappropriate aggression); Sleep-wake cycle disruption (nighttime waking, daytime sleeping, reversed day-night activity); House soiling despite previous reliable training; and Activity changes (reduced play, repetitive behaviours, anxiety, reduced exploration).
CDS involves accumulation of amyloid beta plaques and tau neurofibrillary tangles in the canine brain—directly analogous to human Alzheimer's neuropathology. This positions dogs as a natural model for human dementia research while highlighting the welfare significance of CDS as a genuine neurodegenerative disease rather than a behavioural problem. Brain atrophy and oxidative stress contribute to progressive cognitive decline.
SAMe (S-Adenosyl-methionine) supports neurotransmitter production and has demonstrated cognitive benefit in dogs. Medium-chain triglyceride (MCT) supplementation provides an alternative energy substrate for glucose-deficient neurons. Antioxidant supplementation (vitamin E, vitamin C) reduces oxidative stress. Hill's Prescription Diet b/d is specifically formulated for cognitive support. These approaches demonstrate slowed progression in early-to-moderate CDS when initiated promptly.
Environmental modifications support dogs with cognitive decline: maintaining predictable routines reduces anxiety from confusion; nightlights reduce disorientation in the dark; baby gates prevent access to hazardous areas; and regular cognitive enrichment (training sessions, puzzle feeders, gentle play) maintains neural engagement. Pheromone diffusers and anxiolytic medications manage the anxiety component of CDS. Owner education about the medical basis of CDS reduces frustration and improves caregiver responses.